U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07868432) titled 'Glycemic Impact of NNS Via the Gut Microbiome' on Oct. 05.
Brief Summary: This pilot study will evaluate the feasibility and acceptability of a 30-day sucralose intervention among adults with prediabetes. Participants will consume six commercial sucralose (Splenda(R)) packets daily for 30 days while wearing a blinded continuous glucose monitor (CGM). Oral glucose tolerance tests (OGTTs) with blood draws will be performed at baseline and after 30 days to assess glucose incremental area under the curve (iAUC). Stool samples will also be collected to assess the feasibility of microbiome sample collection for future studies. The study w...